Defender Pharmaceuticals - Crunchbase Company Profile & Funding

Q: How much funding has Defender Pharmaceuticals raised to date?

Defender Pharmaceuticals has raised obfuscated.

Overview

Defender Pharmaceuticals

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Defender Pharmaceuticals

CB Rank

54415

Defender Pharmaceuticals is a privately held life sciences company.

Founded

obfuscation

Private

Funding Round

St Louis, Missouri, United States

11-50

defenderpharma.com/

Health Care

Manufacturing

Pharmaceutical

Funding Rounds

Funding Round

OBF

obfuscation

Key People

Francis E. O’Donnell, Jr.: Founder and Executive Chairman

Details

Legal Name

Defender Pharmaceuticals, Inc

Operating Status

Active

Company Type

For Profit

Founders

Francis E. O’Donnell, Jr.

About the Company

Defender Pharmaceuticals is a privately held life sciences company dedicated to the discovery, development, and commercialization of pharmaceuticals to preserve the health of civilian and military populations.

Phone Number

314.697.1330

Contact Email

info@defenderpharma.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

DPI-386 Intranasal Scopolamine Gel

An intranasal gel formulation of scopolamine designed to provide rapid absorption and fast-acting relief from motion sickness symptoms.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Funding Round - Defender Pharmaceuticals	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - Defender Pharmaceuticals	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - Defender Pharmaceuticals	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - Defender Pharmaceuticals	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - Defender Pharmaceuticals	—	obfuscated obfuscation	—	Funding Round

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Funding Round - Defender Pharmaceuticals	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - Defender Pharmaceuticals	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - Defender Pharmaceuticals	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - Defender Pharmaceuticals	—	obfuscated obfuscation	—	Funding Round
obfuscated obfuscation	Funding Round - Defender Pharmaceuticals	—	obfuscated obfuscation	—	Funding Round